RE: what you highlighted in red How do you see this playing out for G-4? (Not approved by FDA, but within guidelines for treating per AASLD?) I have wondered if like TX with Olysio this year whether the Abbvie G-4 treatment could get some play? Yesterday I didn't think much, today....I wonder. But the agreement you posted ONLY covers G-1